Ferric Citrate 210 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 210 mg
Reference Brands: Auryxia (US & EU)
Category: Nephrology
Ferric Citrate is an iron supplement used to treat iron deficiency anemia and lower phosphate levels in chronic kidney disease (CKD) patients, particularly those on dialysis. It helps manage both anemia and hyperphosphatemia, improving treatment outcomes in CKD and end-stage renal disease (ESRD) patients.
Product Description:
Ferric Citrate is an iron supplement used to treat iron deficiency anemia and manage hyperphosphatemia in chronic kidney disease (CKD) patients, especially those on dialysis. In addition to improving iron levels, Ferric Citrate also helps lower phosphate levels, a common complication in CKD. This dual-action makes it essential for renal care. Available for B2B distribution in the US and EU, Ferric Citrate offers a crucial therapeutic solution for improving the quality of life and treatment outcomes in CKD and end-stage renal disease (ESRD) patients, ensuring effective management of anemia and phosphate balance.
Ferric Citrate — third party manufacturing & bulk supply
Ferric Citrate 210 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Ferric Citrate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Ferric Citrate →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Atrasentan Hydrochloride
Strength:
0.75 mg, 1.25 mg, 10 mg
Form: Tablets
Reference Brands: Xinlay (USA/EU), Vanrafia (USA/LATAM)
View DetailsTiopronin
Strength:
100 mg, 200 mg , 300 mg
Form: Tablets, Capsules
Reference Brands: Thiola (USA), Mercaptamine (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers